CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

A medication already prescribed to relieve menopausal symptoms could also help prevent invasive breast cancer. That's the ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Thankfully, Reuben discovered VEOZAH, an FDA-approved treatment option that’s 100% hormone-free, which she credits to her fewer hot flashes and night sweats. “Because of that, I worry less, have less ...

The study examined how the type of inflammatory response, or the defense mechanism that protects patients ... a highly inflamed tumor, called a hot tumor, was more responsive to immunotherapy.

“This results in fewer hot flash episodes and reduced intensity when they do occur.” Several non-hormonal medications may ... “However, the exact mechanism hasn’t been well studied yet.” ...

Keep reading for their favorites. When hot flashes strike at a moment's notice, one much-needed item is a cooling mist that you can throw in your bag for easy access. "This is instantly refreshing. I ...

If you've struggled with regulating your body temperature (ahem, hot flashes), then you know the impact it can have on your life. No matter how cold the weather is, it can strike anytime.

The variety of non-hormonal treatments for hot flashes includes some antidepressants and gabapentin, typically used for nerve pain. A newer drug, Veozah, was approved by the FDA in 2023 to treat ...